2008-05-15 23:58:59 -
www.celsion.com - CELSION CORPORATION (NASDAQ: CLN), will hold its Annual Meeting of Stockholders on Wednesday, May 21, 2008 at the InterContinental Harbor Court Baltimore, 550 Light Street, Baltimore, MD 21202.
Stockholders who are unable to attend the meeting are invited to participate by telephone; interested parties should dial (877) 604-2080 (domestic) and (706) 902-1383 (international), Conference
ID: 43354090 to register ten minutes before the meeting is scheduled to begin. The meeting can also be accessed via webcast at the Celsion Corporation's website at www.celsion.com.
The proceedings will be archived for audio replay from Wednesday, May 21, 2008 at 12:00 noon until Wednesday, June 4th. The replay can be accessed at (800) 642-1687 (domestic) and (706) 645-9291 (international). The webcast will be archived on the Company's website, www.celsion.com, for 90 days.
About Celsion: Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems.
Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic, and the North Shore Long Island Jewish Health System. (CLN-W)
Cameron Associates
Paul G. Henning, 212-554-5462
phenning@cameronassoc.com 
